These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 26321094)

  • 21. Nanoemulsions in drug delivery: formulation to medical application.
    Tayeb HH; Sainsbury F
    Nanomedicine (Lond); 2018 Oct; 13(19):2507-2525. PubMed ID: 30265218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Docetaxel microemulsion for enhanced oral bioavailability: preparation and in vitro and in vivo evaluation.
    Yin YM; Cui FD; Mu CF; Choi MK; Kim JS; Chung SJ; Shim CK; Kim DD
    J Control Release; 2009 Dec; 140(2):86-94. PubMed ID: 19709639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of ketoconazole on praziquantel pharmacokinetics and the role of CYP3A4 in the formation of X-OH-praziquantel and not 4-OH-praziquantel.
    Nleya L; Thelingwani R; Li XQ; Cavallin E; Isin E; Nhachi C; Masimirembwa C
    Eur J Clin Pharmacol; 2019 Aug; 75(8):1077-1087. PubMed ID: 31089768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the pharmacokinetic-pharmacodynamic relationship of praziquantel in the Schistosoma mansoni mouse model.
    Abla N; Keiser J; Vargas M; Reimers N; Haas H; Spangenberg T
    PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005942. PubMed ID: 28934207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiparticulate system combining taste masking and immediate release properties for the aversive compound praziquantel.
    Münster M; Schoch C; Schmidt C; Breitkreutz J
    Eur J Pharm Sci; 2017 Nov; 109():446-454. PubMed ID: 28887230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of a novel spot-on formulation of praziquantel for dogs.
    Gutiérrez ML; Di Federico G; Dale JA; Minoia JM; Corrales CD; Schaiquevich P; Wikinski S
    Vet Parasitol; 2017 May; 239():46-49. PubMed ID: 28495196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of Nutraceutical Emulsions as Risperidone Delivery Systems: Characterization and Toxicological Studies.
    Igartúa DE; Calienni MN; Feas DA; Chiaramoni NS; Del Valle Alonso S; Prieto MJ
    J Pharm Sci; 2015 Dec; 104(12):4142-4152. PubMed ID: 26359783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physical, morphological and storage stability of clove oil nanoemulsion based delivery system.
    Singh P; Kaur G; Singh A
    Food Sci Technol Int; 2023 Mar; 29(2):156-167. PubMed ID: 34939458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repeated doses of Praziquantel in Schistosomiasis Treatment (RePST) - single versus multiple praziquantel treatments in school-aged children in Côte d'Ivoire: a study protocol for an open-label, randomised controlled trial.
    Hoekstra PT; Casacuberta Partal M; Amoah AS; van Lieshout L; Corstjens PLAM; Tsonaka S; Assaré RK; Silué KD; Meité A; N'Goran EK; N'Gbesso YK; Roestenberg M; Knopp S; Utzinger J; Coulibaly JT; van Dam GJ
    BMC Infect Dis; 2018 Dec; 18(1):662. PubMed ID: 30547750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and microsomal oxidation of praziquantel and its effects on the P450 system in three-month-old lambs infested by Fasciola hepatica.
    Giorgi M; Salvatori AP; Soldani G; Giusiani M; Longo V; Gervasi PG; Mengozzi G
    J Vet Pharmacol Ther; 2001 Aug; 24(4):251-9. PubMed ID: 11555180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medicinal chemistry of antischistosomal drugs: Praziquantel and oxamniquine.
    da Silva VBR; Campos BRKL; de Oliveira JF; Decout JL; do Carmo Alves de Lima M
    Bioorg Med Chem; 2017 Jul; 25(13):3259-3277. PubMed ID: 28495384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of praziquantel-loaded PLGA nanoparticles and evaluation of intestinal permeation by the everted gut sac model.
    Mainardes RM; Chaud MV; Gremião MP; Evangelista RC
    J Nanosci Nanotechnol; 2006; 6(9-10):3057-61. PubMed ID: 17048518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative study on solid self-nanoemulsifying drug delivery and solid dispersion system for enhanced solubility and bioavailability of ezetimibe.
    Rashid R; Kim DW; Yousaf AM; Mustapha O; Fakhar Ud Din ; Park JH; Yong CS; Oh YK; Youn YS; Kim JO; Choi HG
    Int J Nanomedicine; 2015; 10():6147-59. PubMed ID: 26491288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent trends in praziquantel nanoformulations for helminthiasis treatment.
    Mengarda AC; Iles B; F Longo JP; de Moraes J
    Expert Opin Drug Deliv; 2022 Apr; 19(4):383-393. PubMed ID: 35264036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Praziquantel in a clay nanoformulation shows more bioavailability and higher efficacy against murine Schistosoma mansoni infection.
    El-Feky GS; Mohamed WS; Nasr HE; El-Lakkany NM; Seif El-Din SH; Botros SS
    Antimicrob Agents Chemother; 2015; 59(6):3501-8. PubMed ID: 25845870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anticancer efficacy, tissue distribution and blood pharmacokinetics of surface modified nanocarrier containing melphalan.
    Rajpoot P; Bali V; Pathak K
    Int J Pharm; 2012 Apr; 426(1-2):219-230. PubMed ID: 22301424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of self-nanoemulsifying drug delivery systems for the enhancement of solubility and oral bioavailability of fenofibrate, a poorly water-soluble drug.
    Mohsin K; Alamri R; Ahmad A; Raish M; Alanazi FK; Hussain MD
    Int J Nanomedicine; 2016; 11():2829-38. PubMed ID: 27366063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and bioavailability assessment of ramipril nanoemulsion formulation.
    Shafiq S; Shakeel F; Talegaonkar S; Ahmad FJ; Khar RK; Ali M
    Eur J Pharm Biopharm; 2007 May; 66(2):227-43. PubMed ID: 17127045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel praziquantel solid lipid nanoparticle formulation shows enhanced bioavailability and antischistosomal efficacy against murine S. mansoni infection.
    Radwan A; El-Lakkany NM; William S; El-Feky GS; Al-Shorbagy MY; Saleh S; Botros S
    Parasit Vectors; 2019 Jun; 12(1):304. PubMed ID: 31208446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural Elucidation of Poloxamer 237 and Poloxamer 237/Praziquantel Solid Dispersions: Impact of Poly(Vinylpyrrolidone) over Drug Recrystallization and Dissolution.
    Orlandi S; Priotti J; Diogo HP; Leonardi D; Salomon CJ; Nunes TG
    AAPS PharmSciTech; 2018 Apr; 19(3):1274-1286. PubMed ID: 29313262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.